| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Social and Preventive Medicine [P. M., H. J. S., M. R., J. L. F., M. T.], Department of Pediatrics, Center for Diabetes [T. Q.], and Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine [B. G., H. J. S.], University at Buffalo, State University of New York, Buffalo, New York; Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy [P. M., V. K., A. M., S. S., F. B.]; and Section of Pulmonary, Critical Care and Sleep Medicine, Veterans Administration Medical Center, Buffalo, New York 14214 [B. G.]
There is some evidence that glucose and other factors related to glucose metabolism, such as insulin and insulin-like growth-factors (IGFs) may contribute to breast cancer development.
The present study analyzed the hypothesis that serum glucose, insulin levels, and IGF-I pattern are associated with breast cancer using a nested case-control study. Between 1987 and 1992, 10,786 women ages 3569 were recruited in a prospective study in Italy. Women with history of cancer and on hormone therapy were excluded at baseline. At recruitment, blood samples were collected after a 12-h fast between 7:30 and 9:00 a.m. from all of the study participants.
After 5.5 years, 144 breast cancer cases were identified among the participants of the cohort. Four matched controls were chosen for each breast cancer case from members of the cohort who did not develop breast cancer during the follow-up period.
In premenopausal women, glucose was associated with breast cancer risk: the age, body mass index, and reproductive variable adjusted relative risk (RR) for the highest quartile of serum glucose versus the lowest was 2.8 [95% confidence interval (CI), 1.26.5], and P for trend was 0.02. Insulin showed a weaker association with breast cancer, the adjusted RR of the highest quartile versus the lowest was 1.7 (95% CI, 0.74.1), and P for trend was 0.14, whereas the adjusted RR of the highest quartile of IGF-I was 3.1 (95% CI, 1.18.6), and P for trend was 0.01. Increased levels of insulin-like growth factor binding protein-3 (IGFBP)-3 were related to breast cancer risk: the adjusted RR for the highest quartile was 2.1 (95% CI, 0.954.75), and P for trend was 0.02. In postmenopausal women, the associations of glucose, insulin, and IGF-1 pattern were associated with breast cancer risk in heavier subjects characterized by a body mass index higher than 26.
These results indicate that chronic alteration of glucose metabolism is related to breast cancer development.
This article has been cited by other articles:
![]() |
M. J. Gunter, D. R. Hoover, H. Yu, S. Wassertheil-Smoller, J. E. Manson, J. Li, T. G. Harris, T. E. Rohan, X. Xue, G. Y.F. Ho, et al. A Prospective Evaluation of Insulin and Insulin-like Growth Factor-I as Risk Factors for Endometrial Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 921 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ligibel, N. Campbell, A. Partridge, W. Y. Chen, T. Salinardi, H. Chen, K. Adloff, A. Keshaviah, and E. P. Winer Impact of a Mixed Strength and Endurance Exercise Intervention on Insulin Levels in Breast Cancer Survivors J. Clin. Oncol., February 20, 2008; 26(6): 907 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Rose, S. M. Haffner, and J. Baillargeon Adiposity, the Metabolic Syndrome, and Breast Cancer in African-American and White American Women Endocr. Rev., December 1, 2007; 28(7): 763 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sieri, V. Pala, F. Brighenti, N. Pellegrini, P. Muti, A. Micheli, A. Evangelista, S. Grioni, P. Contiero, F. Berrino, et al. Dietary glycemic index, glycemic load, and the risk of breast cancer in an Italian prospective cohort study Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1160 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S Schernhammer, S. S Tworoger, A H. Eliassen, S. A Missmer, J. M Holly, M. N Pollak, and S. E Hankinson Body shape throughout life and correlations with IGFs and GH Endocr. Relat. Cancer, September 1, 2007; 14(3): 721 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E Cust, R. Kaaks, C. Friedenreich, F. Bonnet, M. Laville, A. Tjonneland, A. Olsen, K. Overvad, M. U. Jakobsen, V. Chajes, et al. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Endocr. Relat. Cancer, September 1, 2007; 14(3): 755 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Xue and K. B Michels Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence Am. J. Clinical Nutrition, September 1, 2007; 86(3): 823S - 835S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Tworoger, I-M. Lee, J. E. Buring, M. N. Pollak, and S. E. Hankinson Insulin-like Growth Factors and Ovarian Cancer Risk: A Nested Case-Control Study in Three Cohorts Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1691 - 1695. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Travier, M Jeffreys, N Brewer, C. Wright, C. Cunningham, J Hornell, and N Pearce Association between glycosylated hemoglobin and cancer risk: a New Zealand linkage study Ann. Onc., August 1, 2007; 18(8): 1414 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Micheli, E. Meneghini, G. Secreto, F. Berrino, E. Venturelli, A. Cavalleri, T. Camerini, M. G. Di Mauro, E. Cavadini, G. De Palo, et al. Plasma Testosterone and Prognosis of Postmenopausal Breast Cancer Patients J. Clin. Oncol., July 1, 2007; 25(19): 2685 - 2690. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Baglietto, D. R. English, J. L. Hopper, H. A. Morris, W. D. Tilley, and G. G. Giles Circulating Insulin-Like Growth Factor-I and Binding Protein-3 and the Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 763 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Cade, V. J. Burley, D. C. Greenwood, and the UK Women's Cohort Study Steering Group Dietary fibre and risk of breast cancer in the UK Women's Cohort Study Int. J. Epidemiol., April 1, 2007; 36(2): 431 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. Sinilnikova, J. D. McKay, S. V. Tavtigian, F. Canzian, D. DeSilva, C. Biessy, S. Monnier, L. Dossus, C. Boillot, L. Gioia, et al. Haplotype-Based Analysis of Common Variation in the Acetyl-CoA Carboxylase {alpha} Gene and Breast Cancer Risk: A Case-Control Study Nested within the European Prospective Investigation into Cancer and Nutrition Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 409 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Verheus, P. H.M. Peeters, R. Kaaks, P. A.H. van Noord, D. E. Grobbee, and C. H. van Gils Premenopausal Insulin-Like Growth Factor-I Serum Levels and Changes in Breast Density over Menopause Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 451 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Stattin, O. Bjor, P. Ferrari, A. Lukanova, P. Lenner, B. Lindahl, G. Hallmans, and R. Kaaks Prospective Study of Hyperglycemia and Cancer Risk Diabetes Care, March 1, 2007; 30(3): 561 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Eliassen, S. S. Tworoger, C. S. Mantzoros, M. N. Pollak, and S. E. Hankinson Circulating Insulin and C-Peptide Levels and Risk of Breast Cancer among Predominately Premenopausal Women Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 161 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pacher, M. J. Seewald, M. Mikula, S. Oehler, M. Mogg, U. Vinatzer, A. Eger, N. Schweifer, R. Varecka, W. Sommergruber, et al. Impact of constitutive IGF1/IGF2 stimulation on the transcriptional program of human breast cancer cells Carcinogenesis, January 1, 2007; 28(1): 49 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Tran, C. Diorio, S. Berube, M. Pollak, and J. Brisson Relation of insulin-like growth factor (IGF) I and IGF-binding protein 3 concentrations with intakes of fruit, vegetables, and antioxidants Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1518 - 1526. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. BERRINO, A. VILLARINI, M. DE PETRIS, M. RAIMONDI, and P. PASANISI Adjuvant Diet to Improve Hormonal and Metabolic Factors Affecting Breast Cancer Prognosis Ann. N.Y. Acad. Sci., November 1, 2006; 1089(1): 110 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G Renehan, M. Harvie, and A. Howell Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. Endocr. Relat. Cancer, June 1, 2006; 13(2): 273 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
A M Lorincz and S Sukumar Molecular links between obesity and breast cancer. Endocr. Relat. Cancer, June 1, 2006; 13(2): 279 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S Schernhammer, J. M Holly, D. J Hunter, M. N Pollak, and S. E Hankinson Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Endocr. Relat. Cancer, June 1, 2006; 13(2): 583 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Rinaldi, P H M Peeters, F Berrino, L Dossus, C Biessy, A Olsen, A Tjonneland, K Overvad, F Clavel-Chapelon, M C Boutron-Ruault, et al. IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr. Relat. Cancer, June 1, 2006; 13(2): 593 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Missmer, D. Spiegelman, E. R. Bertone-Johnson, R. L. Barbieri, M. N. Pollak, and S. E. Hankinson Reproducibility of Plasma Steroid Hormones, Prolactin, and Insulin-like Growth Factor Levels among Premenopausal Women over a 2- to 3-Year Period. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 972 - 978. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Cleveland, M. D. Gammon, S. N. Edmiston, S. L. Teitelbaum, J. A. Britton, M. B. Terry, S. M. Eng, A. I. Neugut, R. M. Santella, and K. Conway IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project Carcinogenesis, April 1, 2006; 27(4): 758 - 765. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. de Assis, M. Wang, S. Goel, A. Foxworth, W. Helferich, and L. Hilakivi-Clarke Excessive Weight Gain during Pregnancy Increases Carcinogen-Induced Mammary Tumorigenesis in Sprague-Dawley and Lean and Obese Zucker Rats J. Nutr., April 1, 2006; 136(4): 998 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P.M. Suijkerbuijk, F. J.B. Van Duijnhoven, C. H. Van Gils, P. A.H. Van Noord, P. H.M. Peeters, C. M. Friedenreich, and E. M. Monninkhof Physical activity in relation to mammographic density in the dutch prospect-European prospective investigation into cancer and nutrition cohort. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 456 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lin, P. M. Ridker, N. Rifai, I-M. Lee, J. E. Manson, J. E. Buring, and S. M. Zhang A Prospective Study of Hemoglobin A1c Concentrations and Risk of Breast Cancer in Women. Cancer Res., March 1, 2006; 66(5): 2869 - 2875. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Diorio, M. Pollak, C. Byrne, B. Masse, N. Hebert-Croteau, M. Yaffe, G. Cote, S. Berube, and J. Brisson Levels of C-Peptide and Mammographic Breast Density Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2661 - 2664. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Canzian, J. D. McKay, R. J. Cleveland, L. Dossus, C. Biessy, C. Boillot, S. Rinaldi, M. Llewellyn, V. Chajes, F. Clavel-Chapelon, et al. Genetic Variation in the Growth Hormone Synthesis Pathway in Relation to Circulating Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and Breast Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition Study Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2316 - 2325. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O. Keku, P. K. Lund, J. Galanko, J. G. Simmons, J. T. Woosley, and R. S. Sandler Insulin Resistance, Apoptosis, and Colorectal Adenoma Risk Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2076 - 2081. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Diorio, M. Pollak, C. Byrne, B. Masse, N. Hebert-Croteau, M. Yaffe, G. Cote, S. Berube, C. Morin, and J. Brisson Insulin-Like Growth Factor-I, IGF-Binding Protein-3, and Mammographic Breast Density Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1065 - 1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Schernhammer, J. M. Holly, M. N. Pollak, and S. E. Hankinson Circulating Levels of Insulin-like Growth Factors, their Binding Proteins, and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 699 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Fletcher, L. Gibson, N. Johnson, D. R. Altmann, J. M.P. Holly, A. Ashworth, J. Peto, and I. d. S. Silva Polymorphisms and Circulating Levels in the Insulin-Like Growth Factor System and Risk of Breast Cancer: A Systematic Review Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 2 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rinaldi, R. Kaaks, A. Zeleniuch-Jacquotte, A. A. Arslan, R. E. Shore, K. L. Koenig, L. Dossus, E. Riboli, P. Stattin, A. Lukanova, et al. Insulin-Like Growth Factor-I, IGF Binding Protein-3, and Breast Cancer in Young Women: A Comparison of Risk Estimates Using Different Peptide Assays Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 48 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Voskuil, A. Vrieling, L. J. van't Veer, E. Kampman, and M. A. Rookus The Insulin-like Growth Factor System in Cancer Prevention: Potential of Dietary Intervention Strategies Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 195 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Platek, V. Krogh, A. Micheli, R. Browne, E. Meneghini, S. Sieri, H. J. Schunemann, V. Pala, M. Barba, G. E. Wilding, et al. Serum Fructosamine and Subsequent Breast Cancer Risk: A Nested Case-Control Study in the ORDET Prospective Cohort Study Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 271 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. MUTI The Role of Endogenous Hormones in the Etiology and Prevention of Breast Cancer: The Epidemiological Evidence Ann. N.Y. Acad. Sci., December 1, 2004; 1028(1): 273 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tran, B. S. Bharaj, E. P. Diamandis, M. Smith, B. D. L. Li, and H. Yu Short Tandem Repeat Polymorphism and Cancer Risk: Influence of Laboratory Analysis on Epidemiologic Findings Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2133 - 2140. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Chlebowski, M. Pettinger, M. L. Stefanick, B. V. Howard, Y. Mossavar-Rahmani, and A. McTiernan Insulin, Physical Activity, and Caloric Intake in Postmenopausal Women: Breast Cancer Implications J. Clin. Oncol., November 15, 2004; 22(22): 4507 - 4513. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ren, Q. Cai, X.-O. Shu, H. Cai, C. Li, H. Yu, Y.-T. Gao, and W. Zheng Genetic Polymorphisms in the IGFBP3 Gene: Association with Breast Cancer Risk and Blood IGFBP-3 Protein Levels among Chinese Women Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1290 - 1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Singer, M. Mogg, W. Koestler, M. Pacher, E. Marton, E. Kubista, and M. Schreiber Insulin-Like Growth Factor (IGF)-I and IGF-II Serum Concentrations in Patients with Benign and Malignant Breast Lesions: Free IGF-II Is Correlated with Breast Cancer Size Clin. Cancer Res., June 15, 2004; 10(12): 4003 - 4009. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Holmes, S. Liu, S. E. Hankinson, G. A. Colditz, D. J. Hunter, and W. C. Willett Dietary Carbohydrates, Fiber, and Breast Cancer Risk Am. J. Epidemiol., April 15, 2004; 159(8): 732 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. T. Bloomgarden Definitions of the Insulin Resistance Syndrome: The 1st World Congress on the Insulin Resistance Syndrome Diabetes Care, March 1, 2004; 27(3): 824 - 830. [Full Text] [PDF] |
||||
![]() |
M. S. Sandhu, J. M. Gibson, A. H. Heald, D. B. Dunger, and N. J. Wareham Association between Insulin-Like Growth Factor-I: Insulin-Like Growth Factor-Binding Protein-1 Ratio and Metabolic and Anthropometric Factors in Men and Women Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 166 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cho, D. Spiegelman, D. J. Hunter, W. Y. Chen, G. A. Colditz, and W. C. Willett Premenopausal Dietary Carbohydrate, Glycemic Index, Glycemic Load, and Fiber in Relation to Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1153 - 1158. [Abstract] [Full Text] |
||||
![]() |
H. Yu, X.-O. Shu, B. D. L. Li, Q. Dai, Y.-T. Gao, F. Jin, and W. Zheng Joint Effect of Insulin-like Growth Factors and Sex Steroids on Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1067 - 1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Muti RE: "SERUM INSULIN AND GLUCOSE LEVELS AND BREAST CANCER INCIDENCE: THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY" Am. J. Epidemiol., September 15, 2003; 158(6): 607 - 607. [Full Text] [PDF] |
||||
![]() |
Endogenous Hormones Breast Cancer Collaborative Gr Body Mass Index, Serum Sex Hormones, and Breast Cancer Risk in Postmenopausal Women J Natl Cancer Inst, August 20, 2003; 95(16): 1218 - 1226. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Chang, E.-K. Seo, C. Gyllenhaal, and K. I. Block Panax ginseng: Panax ginseng: A Role in Cancer Therapy? Integr Cancer Ther, March 1, 2003; 2(1): 13 - 33. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |